Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
This connection may be attributable to lower iron levels.
A new study analyzed how non-alcoholic fatty liver disease affects maternal health outcomes.
Non-alcoholic fatty liver disease can be driven by toxin exposure.
Instead of non-alcoholic fatty liver disease, they suggest calling it metabolic-associated fatty liver disease.
Researchers believe this finding may have implications for human health.
New research is emerging about how the respiratory virus spreads and how people can protect themselves and others.
Liver scarring was associated with poorer health outcomes and a higher risk of death for people with non-alcoholic fatty liver disease.
Women have a lower risk of heart disease than men, but this protective effect is diminished in those with fatty liver disease.
A new study suggested that a compound found in veggies such as broccoli, kale and Brussels sprouts may help maintain liver health.
Those with fatty liver disease and cirrhosis should undergo regular screening.
About a quarter of people taking a higher dose of Ocaliva saw an improvement in liver fibrosis.
Three fatty liver disease candidates miss the mark for effectiveness or safety.
Hepatitis B and C, non-alcoholic steatohepatitis (NASH) and alcohol-related liver disease are the main causes of liver cancer and cirrhosis.
The herbicide has been making headlines over allegations it could be linked to cancer—but scientists say there are other risks too.
Non-alcoholic steatohepatitis, or NASH, is a form of non-alcoholic fatty liver disease.
Madrigal Pharmaceuticals is the latest company to enter into what’s becoming a crowded market.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.